Established in 2018 by primary metagenomics scientists at UC Berkeley, Brian C. Thomas and Jillian Banfield, Metagenomi is dedicated to transforming the field of cell and gene therapies. Through the utilization of metagenomics to uncover 4 billion years of microorganism evolution, Metagenomi is swiftly discovering and defining new nucleases with distinctive gene editing capabilities. Metagenomi is utilizing this expanded gene editing arsenal to create groundbreaking in vivo and ex vivo treatments.
Metagenomi
Headquarters
United States of America